Sutro Biopharma, Inc.
About Sutro Biopharma, Inc.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Underwritten Offering T: - FT: Underwritten Offering |
A: 75000000 MR: - FA: $75 million FAN: 75000000 |
D: 2024-04-02 FD: 2024-04-02 |
1 investors |
| 2 |
RT: Royalty Financing T: - FT: Royalty Financing |
A: 140000000 MR: - FA: $140 million upfront FAN: 140000000 |
D: 2023-06-26 FD: 2023-06-26 |
1 investors |
Growth Metrics
Team & Leadership
Lawrence Fong
Member, Scientific Advisory Board
Anthony W. Tolcher
Member, Scientific Advisory Board
Ana Oaknin Benzaquen
Member, Clinical Advisory Board
R. Wendel Naumann
Member, Clinical Advisory Board
D. Ross Camidge
Member, Scientific Advisory Board
Carlos V. Paya
Chair, Scientific Advisory Board
Recent News
Sutro Biopharma, Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- sutrobio.com
- Industries
- Biotechnology
- Company Size
- ~460 employees (est.)
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro